HUM-MOLGEN events: PharmAsia Summit

Monday, October 21, 2013

11:30-12:30pm

Registration and Box Lunch Grand Ballroom Foyer

12:30PM

Welcome and Opening Remarks, Elsevier Business Intelligence and Bay Helix

Science Park Day Recap-- Grand Ballroom I + II

Joshua Berlin, Head of Emerging Markets, Elsevier Business Intelligence

Jun Bao, PhD, Senior Vice President and Chief Business Officer, Shenogen Pharma Group Ltd.

Jialing Dai, China Bureau Chief, PharmAsia News, Elsevier Business Intelligence

Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

12:45-1:45PM

Sanofi’s Asia Strategy: The Strategic Importance Of China

Jean-Luc Lowinski, PhD, Senior Vice President, Asia, President, China, Sanofi

1:45-2:45PM

Tapping China’s “Broader” Market: Challenges And Opportunities For MNCs

Sponsored by Kantar Health

Simon Li, General Manager, Kantar Health China (Moderator)

Gan Ding, General Manager, Broad Market Business, Cardinal Health China

Cheng Zhang, Manager, Strategy & Business Development, Pfizer China

Jenny Zhu, Head of KA Strategy & Excellence, GlaxoSmithKline

2:45-3:15PM

Networking Break Grand Ballroom Foyer

3:15-4:00PM

Drug and Device “Localization”: Pathways and Perils

Sponsored by Sidley Austin

Lei Li, Counsel, Sidley Austin LLP (Moderator)

C. Charles Tong, PhD, General Manager of R&D Center, Hisun-Pfizer Pharmaceuticals Company Limited (INVITED)

4:00-5:00PM

Doing Business Development In China Today: An Analysis Of Top Deal Structures

Sponsored by Navigant Consulting, Inc.

Paul Zhang, Managing Director, Life Sciences, Navigant (Moderator)

Sundeep Lal, PhD, Vice President, Strategy, Business Development & Business Model Innovation, Medtronic

Hai Mi, PhD, Venture Partner, Softbank China Venture Capital

Cezary Statuch, Vice President, China R&D, Bristol-Myers Squibb

Larry Zhu, PhD, Vice President, Strategic Collaboration, Zhejiang Beta Pharma

5:00-6:15PM

Opening Plenary Session: In Search Of New Growth Models For Big Pharma In China:

Joshua Berlin, Head of Emerging Markets, Elsevier Business Intelligence (Moderator)

Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company., Inc.

Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

6:15-8:00PM

Welcome Reception - -- Grand Ballroom III

Tuesday, October 22, 2013

7:30-8:30am

Breakfast Networking & Facilitated Discussions -- Crystal Ballroom II +III

Table 1: The Commercial Challenge, facilitated by Simon Yan, Navigant Consulting, Inc.

Table 2: The R&D Challenge, facilitated by Fangning Zhang, McKinsey & Company, Inc.

Table 3: The Regulatory and Reimbursement Challenge, facilitated by Ropes & Gray

Table 4: The Personalized Medicine Challenge, facilitated by Jay Dong, Cell Signal Technology

Table 5: The BD and Funding Challenge, facilitated by Charles Hsu, Mustang Ventures

8:30-8:45am

Welcome, Elsevier & Bay Helix -- Grand Ballroom I + II

Opening Remarks & Meeting Overview

Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company Inc.

8:45-9:30am

Fueling Roche's Growth: The Importance Of The Asia Pacific Region

Luke Miels, Regional Head, Asia Pacific, Roche Singapore Pte Ltd.

9:30-11:00AM

Defining A China-based Innovation Strategy: Should Early Stage R&D Be A Priority?

George Baeder, Director, Research Works (Moderator)

Patrecia Flynn-Valone, Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center

Henry He Sun, PhD, Vice President, China Tasly Group; Co-founder and CEO, Tasly Pharmaceuticals, Inc.

Steve Yang, PhD, Vice President, Head of Asia and Emerging Markets iMed, AstraZeneca PLC

Lianshan Zhang, PhD, President of Global R&D, Jiangsu Hengrui Medicine

Ming Zhang, PhD, Head of R&D China, Amgen, Inc.

11:00-11:30AM

Networking Break Grand Ballroom Foyer

11:30-12:30PM

The New Goldrush: Biologics Investment In China Grand Ballroom I + II

Bin Li, PhD, Managing Director, Morgan Stanley (Moderator)

Jeremy Caudill, Global Vice President Business Development, Samsung BioLogics

Racho Jordanov, President and CEO, JHL Biotech

Jimmy Wei, PhD, Venture Partner, KPCB China

Michael Yu, PhD, President and CEO, Innovent Biologics Inc.

12:30-1:30PM

Regulatory Insight: Strategies To Accelerate The Time To Market

Ling Su, PhD, Strategic Advisor, Life Sciences, Sidley Austin LLP (Moderator)

Benny Li, PhD, Vice President and Head of Development, Takeda Shanghai Development Center

Ning Li, MD, PhD, Vice President, GRA , Head of Asia Regulatory and Medical Policy, Sanofi

Weiping Li, Head of Regulatory Affairs, Xian-Janssen Pharmaceutical Ltd.

George Yeh, President, Taiwan Liposome Company, Ltd.

1:30-2:45PM

Lunch + Elsevier-Bay Helix Awards Ceremony Crystal Ballroom II +III

-- Grand Ballroom I + II

Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co. Inc.

R&D Achievement Of The Year

Alliance Of The Year

Commercial Achievement Of The Year

R&D Leadership Award

2:45PM3:30PM

At The Intersection Of Drug Distribution And Health Care Policy: The View From Cardinal China Grand Ballroom I + II

Eric Zwisler, President, China, Cardinal Health China

3:30-4:30PM

Debate: What’s Needed Now To Support Early Stage China Biotechs

Kewen Jin, PhD, Managing Director, Nimbus Innoworks (Moderator)

Samantha Du, Managing Director, Sequoia Capital China

Carl Firth, PhD, CEO, Aslan Pharmaceuticals

John Oyler, Founder and CEO, BeiGene Ltd.

Jonathan Wang, PhD, Senior Managing Director, OrbiMed

4:30-4:45PM

Networking Break Grand Ballroom Foyer

4:45-6:00PM

BD In China: Aligning For Innovation (PAS/PSA Showcase Panel) -- Grand Ballroom I + II

Debra Yu, MD, Managing Director, Labrador Advisors (Moderator)

Jun Bao, PhD, Senior Vice President and Chief Business Officer, Shenogen Pharma Group Ltd.

Sammy Hua Jiang, Vice President (International Business), Luye Pharma Group

Sophie Kornowski-Bonnet, PhD, Head of Partnering, Roche

Da Liu, Senior, Business Development Director, China Resources Pharmaceutical Group Ltd.

Jimmy Zhang, PhD, Managing Director, MSD Early Investments – Greater China, Merck & Co., Inc.

6:00pm

Cocktail Reception -- Grand Ballroom III

Wednesday, October 23, 2013

7:45-8:45am

Breakfast Networking Crystal Ballroom II + III

8:45-9:00AM

Recap of Tuesday’s Key Learnings & Wednesday Overview -- Grand Ballroom I + II

Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company, Inc.

9:00-10:00AM

In Focus: What’s Needed Now To Improve Compliance

Brian Yang, Senior Writer, PharmAsia News, Elsevier Business Intelligence (Moderator)

Joseph Cho, Managing Director, R&D-based Pharmaceutical Association Committee (RDPAC)

Ruilin Song, Executive President, SINO-PhIRDA

10:00AM – 11:00AM

Bridging The Affordability Gap: Bringing Innovation To Market Access

Paul Zhang, Managing Director, Navigant (Moderator)

Robert Braithwaite, Chairman and CEO, Luqa Pharmaceuticals

Howard Gough, Managing Director, CGHB, Asia Pacific, CIGNA

Harald Sprenger, Director Access, Asia-Pacific, Roche Pharmaceuticals

Julie Xing, PhD, VP Head Oncology Business Unit, Lilly China

11:00AM – 11:30AM

Networking Break Grand Ballroom Foyer

11:30AM - 12:45PM

Pricing Pressure: Winning Strategies In An Era Of Cost Containment -- Grand Ballroom I + II

Franck Le Deu, Leader of Greater China Healthcare Practice, McKinsey & Company., Inc. (Moderator)

Guohong Shan, General Manager, Specialty Care Business Unit, Pfizer

Xin Wu, UCB

Richard Yeh, MD, Head of China Healthcare Research, Citi Research

Ingrid Zhang, Head of Specialty Business, Novartis Pharma Greater China

12:45PM -2:15PM

Taking the Long View: The Perspective Of A China GM(Includes 30 minutes for box lunch)

Tamra Sami, Managing Editor, PharmAsia News, Elsevier Business Intelligence (Moderator)

David Snow, President, China and Hong Kong, AstraZeneca

2:15PM

Conference Concludes